SER
Financials
- Market Capitalization 62.49 M
- Employee 16
- Founded 2006
- CEO N/A
- Website www.serinatherapeutics.com
- Headquarter Alabama, United States
- FIGI BBG00HCXQ7B0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4165 |  INMB INmune Bio Inc. - Common stock | 2.33 USD | -2.92% | +0.43% | +37.87% | +16.50% | 64.67 M USD | ||
| 4180 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.33 USD | 0.00% | +3.13% | -32.65% | -75.56% | 62.65 M USD | ||
| 4189 |  ELOX Eloxx Pharmaceuticals, Inc. | 15.07 USD | -5.81% | -23.70% | +21.43% | +50.70% | 60.83 M USD | ||
| 4191 |  IMA ImageneBio, Inc. - Common Stock | 5.34 USD | +0.19% | -5.99% | -4.64% | -60.18% | 60.62 M USD |
Frequently asked questions about Serina Therapeutics, Inc.
What is the Serina Therapeutics, Inc. stock price today?
The current price of Serina Therapeutics, Inc. (SER) is 2.46. Over the past 24 hours, the stock has changed by -4.28%. Follow the SER chart for real-time price dynamics.
What is the stock ticker of Serina Therapeutics, Inc.?
Serina Therapeutics, Inc. trades under the ticker SER. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Serina Therapeutics, Inc. stock going up?
SER has changed by -12.77% over the last week, +23.00% over the last month, and +47.75% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Serina Therapeutics, Inc.?
Serina Therapeutics, Inc. currently has a market capitalization of 62.49 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Serina Therapeutics, Inc. earnings last quarter?
Last quarter, Serina Therapeutics, Inc. reported earnings of -0.55 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Serina Therapeutics, Inc. revenue for the last quarter?
Serina Therapeutics, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Serina Therapeutics, Inc. net income for the last quarter?
Serina Therapeutics, Inc. reported net income of -6.36 M for the last quarter. The previous quarter showed -6.9 M, which means net income changed by +7.86%.
How many employees does Serina Therapeutics, Inc. have?
As of the latest available data, Serina Therapeutics, Inc. has 16 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Serina Therapeutics, Inc. stock?
You can buy Serina Therapeutics, Inc. (SER) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Serina Therapeutics, Inc. stock?
Investing in Serina Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SER chart and related analysis on metatrader.com as part of your research.